UK drugmaker to acquire US biotech specialising in rare disease treatment
Home/FT/AstraZeneca to buy Alexion in $39bn immunology deal FT AstraZeneca to buy Alexion in $39bn immunology deal Financial Times0 Less than a minute Facebook X LinkedIn UK drugmaker to acquire US biotech specialising in rare disease treatment Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook Share on WhatsApp (Opens in new window) WhatsApp Email a link to a friend (Opens in new window) Email Related Financial Times0 Less than a minute Facebook X LinkedIn Facebook X LinkedIn Tumblr Pinterest Reddit VKontakte Share via Email Print
